company background image
0HF3 logo

Cencora LSE:0HF3 Stock Report

Last Price

US$242.53

Market Cap

US$48.3b

7D

2.1%

1Y

58.6%

Updated

24 Mar, 2024

Data

Company Financials +

0HF3 Stock Overview

Cencora, Inc. sources and distributes pharmaceutical products.

0HF3 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance3/6
Financial Health3/6
Dividends0/6

Cencora, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cencora
Historical stock prices
Current Share PriceUS$242.53
52 Week HighUS$243.78
52 Week LowUS$156.90
Beta0.45
1 Month Change2.56%
3 Month Change19.09%
1 Year Change58.65%
3 Year Change105.03%
5 Year Change216.95%
Change since IPO129.93%

Recent News & Updates

Recent updates

Shareholder Returns

0HF3GB HealthcareGB Market
7D2.1%-0.6%2.3%
1Y58.6%-21.2%4.9%

Return vs Industry: 0HF3 exceeded the UK Healthcare industry which returned -21.2% over the past year.

Return vs Market: 0HF3 exceeded the UK Market which returned 4.9% over the past year.

Price Volatility

Is 0HF3's price volatile compared to industry and market?
0HF3 volatility
0HF3 Average Weekly Movement2.5%
Healthcare Industry Average Movement7.7%
Market Average Movement4.7%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0HF3 has not had significant price volatility in the past 3 months.

Volatility Over Time: 0HF3's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200144,000Steve Collishttps://www.cencora.com

Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

Cencora, Inc. Fundamentals Summary

How do Cencora's earnings and revenue compare to its market cap?
0HF3 fundamental statistics
Market capUS$48.32b
Earnings (TTM)US$1.87b
Revenue (TTM)US$271.58b

25.9x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0HF3 income statement (TTM)
RevenueUS$271.58b
Cost of RevenueUS$262.43b
Gross ProfitUS$9.15b
Other ExpensesUS$7.28b
EarningsUS$1.87b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)9.37
Gross Margin3.37%
Net Profit Margin0.69%
Debt/Equity Ratio450.3%

How did 0HF3 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

21%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.